Hans van Houte

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Hans van Houte
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans van Houte:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 28,584 $702,464 $20.48 30 Oct 2025 Direct
Nurix Therapeutics, Inc. Chief Financial Officer Common Stock 37,592 $472,181 $12.56 03 Nov 2025 Direct
Nurix Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 75,000 11 Feb 2025 Direct

Insider Reports Filed by Hans van Houte

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NRIX Nurix Therapeutics, Inc. 03 Nov 2025 1 -$78,931 4 Chief Financial Officer 03 Nov 2025, 19:14
NRIX Nurix Therapeutics, Inc. 30 Oct 2025 9 -$40,054 4 Chief Financial Officer 30 Oct 2025, 18:06
NRIX Nurix Therapeutics, Inc. 01 Aug 2025 1 -$59,598 4 Chief Financial Officer 01 Aug 2025, 17:09
NRIX Nurix Therapeutics, Inc. 30 Jul 2025 9 -$51,695 4 Chief Financial Officer 30 Jul 2025, 18:49
NRIX Nurix Therapeutics, Inc. 02 May 2025 1 -$70,243 4 Chief Financial Officer 02 May 2025, 18:18
NRIX Nurix Therapeutics, Inc. 30 Apr 2025 7 -$28,041 4 Chief Financial Officer 30 Apr 2025, 19:35
NRIX Nurix Therapeutics, Inc. 03 Mar 2025 2 -$84,388 4 Chief Financial Officer 03 Mar 2025, 17:29
NRIX Nurix Therapeutics, Inc. 11 Feb 2025 2 $0 4 Chief Financial Officer 13 Feb 2025, 16:12
NRIX Nurix Therapeutics, Inc. 30 Jan 2025 8 -$55,809 4 Chief Financial Officer 30 Jan 2025, 19:43
NRIX Nurix Therapeutics, Inc. 01 Nov 2024 1 -$86,083 4 Chief Financial Officer 01 Nov 2024, 17:57
NRIX Nurix Therapeutics, Inc. 30 Oct 2024 7 -$57,554 4 Chief Financial Officer 30 Oct 2024, 20:30
NRIX Nurix Therapeutics, Inc. 26 Aug 2024 1 -$504,370 4 Chief Financial Officer 26 Aug 2024, 17:41
NRIX Nurix Therapeutics, Inc. 01 Aug 2024 2 -$74,576 4 Chief Financial Officer 01 Aug 2024, 19:06
NRIX Nurix Therapeutics, Inc. 30 Jul 2024 7 -$51,463 4 Chief Financial Officer 30 Jul 2024, 19:06
NRIX Nurix Therapeutics, Inc. 20 Jun 2024 1 -$400,216 4 Chief Financial Officer 20 Jun 2024, 16:58
NRIX Nurix Therapeutics, Inc. 02 May 2024 1 -$44,878 4 Chief Financial Officer 02 May 2024, 18:01
NRIX Nurix Therapeutics, Inc. 30 Apr 2024 5 -$16,703 4 Chief Financial Officer 30 Apr 2024, 18:33
NRIX Nurix Therapeutics, Inc. 16 Feb 2024 1 -$68,223 4 Chief Financial Officer 16 Feb 2024, 19:20
NRIX Nurix Therapeutics, Inc. 13 Feb 2024 2 $0 4 Chief Financial Officer 15 Feb 2024, 07:23
NRIX Nurix Therapeutics, Inc. 30 Jan 2024 5 -$13,352 4 Chief Financial Officer 30 Jan 2024, 18:53
NRIX Nurix Therapeutics, Inc. 20 Dec 2023 1 -$35,421 4 Chief Financial Officer 21 Dec 2023, 17:19
NRIX Nurix Therapeutics, Inc. 19 Dec 2023 1 -$109,093 4 Chief Financial Officer 20 Dec 2023, 16:55
NRIX Nurix Therapeutics, Inc. 30 Oct 2023 5 -$5,613 4 Chief Financial Officer 01 Nov 2023, 16:41
NRIX Nurix Therapeutics, Inc. 30 Jul 2023 5 -$12,020 4 Chief Financial Officer 01 Aug 2023, 16:28
NRIX Nurix Therapeutics, Inc. 30 Apr 2023 3 -$7,121 4 Chief Financial Officer 02 May 2023, 16:33
NRIX Nurix Therapeutics, Inc. 14 Feb 2023 2 $0 4 Chief Financial Officer 15 Feb 2023, 15:13
NRIX Nurix Therapeutics, Inc. 30 Jan 2023 3 -$10,884 4 Chief Financial Officer 01 Feb 2023, 15:17
NRIX Nurix Therapeutics, Inc. 30 Oct 2022 3 -$9,519 4 Chief Financial Officer 01 Nov 2022, 19:35
NRIX Nurix Therapeutics, Inc. 09 Aug 2022 1 $0 4 Chief Financial Officer 10 Aug 2022, 16:17
NRIX Nurix Therapeutics, Inc. 30 Jul 2022 3 -$11,784 4 Chief Financial Officer 02 Aug 2022, 17:46
NRIX Nurix Therapeutics, Inc. 31 May 2022 2 +$57,400 4 Chief Financial Officer 01 Jun 2022, 16:57
NRIX Nurix Therapeutics, Inc. 30 Apr 2022 3 -$8,190 4 Chief Financial Officer 03 May 2022, 19:03
NRIX Nurix Therapeutics, Inc. 19 Jan 2022 2 $0 4 Chief Financial Officer 21 Jan 2022, 15:16